Disclosed are methods for treating gastrointestinal disorders, e.g.,
Crohn's disease, ulcerative colitis, and diverticular disease, with a
granulated mesalamine formulation. Some formulations use granulated
mesalamine in capsule form. Also included are methods to extend remission
of ulcerative colitis by administration of a once-daily dosage of
granulated mesalamine.